Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Refills and Ongoing Support Medication refills are timed to the selected program duration
Through the program, which runs through December 31, 2027, eligible Medicare beneficiaries can access certain GLP1 medications for $50 per month, offering more predictable and affordable pricing for patients who qualify
However, nausea is the most commonly reported adverse effect, with incidence varying by medication and dose: approximately 15-30% for most GLP-1 agonists and up to 30-44% at higher doses of semaglutide and tirzepatide according to FDA prescribing information
Y.TsaiY
doi:10.1111/COB.12734 58
Clinical trial data demonstrate that tirzepatide produces substantial benefits for adults with type 2 diabetes and obesity
US$ 25.31
US$ 24.90
US$ 25.30
US$ 28.53
